Dr. Scott Rocklage is well known for his managing partner role at 5 AM Venture Management LLC. He also serves in the same position at 5 AM Ventures IV, L.P. He joined the leadership team of 5 AM Ventures in 2003. He owns and co-owns more than 30 patents that are used in the U.S. healthcare sector. Scott has over 100 peer-reviewed publications.
Besides working for 5 AM Venture Management, he used to work for EPIRUS Biopharmaceuticals as the chief executive officer for three months. He also held the same position at Amersham Health. Ilypsa, Inc. appointed him as the executive board chairperson and co-president. Scott Rocklage was the first CEO of Cubist Pharmaceuticals Inc. He also served as the president of the company from 1994 to 2001. During his leadership, the company collaborated with several renowned pharmaceuticals. Before joining Cubist Pharmaceuticals, Nycomed Salutar hired him as CEO and president. He headed the executive board of Nycomed Interventional as the chairperson. Scott also worked as the company’s CEO and president for two years.
Executive Board Roles
Scott has been the chairperson of the boards of several pharmaceutical companies. These include Cidara Therapeutics, Novira Therapeutics, and Rennovia Inc. Scott is the executive chair of Whitehead Institute’s board of associates.
Scott’s expertise lies in healthcare management and scientific research. He has an admirable record of achievement in leadership. He attended the University of California, Berkeley for a degree in chemistry. Dr. Scott also obtained a doctorates degree in chemistry from Massachusetts Institute of Technology (MIT). As a Ph.D. student at MIT, he researched on the laboratory of Richard Schrock. He was passionate about the accomplishments of Richard, who won a Nobel Prize. Scott once mentioned that MIT laid a foundation for his professional life and career. When he joined the Richard Schrock research group at MIT, he knew that he was going to accomplish a lot. In the group, he had his unique mechanism for success.
In 2016, Scott and his wife visited an MIT chemistry lab. The purpose of their visit was to contribute funds for the renovation of a nanochemistry and nanotechnology lab. Scott supported the renovation project since he had spent most of his Ph.D. study time in the chemistry department. The chemistry department head, Timothy Jamison, was thrilled by Scott’s contributions. In 2010, Scott gave remarks on how his principles enabled him to be part of a great research group at MIT. His remarks were published in a newsletter of the MIT chemistry department. He was honored to have worked with top minds as he was finalizing his Ph.D. Scott also recognized Clayton Wood, Jere Fellman, and Howard Turner, who were his supportive friends at MIT.